Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IEF vs GSK✓SelectedUSD · GSKIEF vs GSK performance historyLatest closeAs of+0.22%11/16
Stock and ETF performance explorer

IEF vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+9.2%
GSK return
+64.4%
Excess return
-55.3%
Maximum drawdown
-6.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-0.1%+0.3%+0.2%
7D-1.7%-1.3%-0.4%-1.6%
30D+0.1%+2.7%-2.6%0.0%
3M-2.0%+2.7%-4.7%-2.2%
6M-1.5%+3.3%-4.8%-1.8%
YTD-3.0%+6.5%-9.4%-3.4%
1Y-2.7%+10.7%-13.3%-3.3%
3Y+9.2%+64.4%-55.2%+6.7%
All+9.2%+64.4%-55.3%+6.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling